Pancreatic autoantibodies after pancreas-kidney transplantation - do they matter?

Clinical Transplantation

Volumn 28, Issue 4, 2014, Pages 462-469

  Martins, La Salete ^a   Henriques, Antonio C ^a   Fonseca, Isabel M ^a   Rodrigues, Anabela S ^a   Oliverira, José C ^a   Dores, Jorge M ^a   Dias, Leonidio S ^a   Cabrita, Antonio M ^a   Silva, José D ^a   Noronha, Irene L ^b  

^a HOSPITAL DE SANTO ANTÓNIO   (Portugal)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Autoantibodies; Autoimmunity; Pancreas transplantation; Recurrence

Indexed keywords

AUTOANTIBODY; C PEPTIDE; GLUCOSE; GLUTAMATE DECARBOXYLASE ANTIBODY; HEMOGLOBIN A1C; IMMUNOGLOBULIN; INSULIN ANTIBODY; MYCOPHENOLIC ACID; PANCREAS ISLET CELL ANTIBODY; RITUXIMAB; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; AUTOANTIGEN; BIOLOGICAL MARKER;

ACUTE GRAFT REJECTION; ADULT; ANTIBODY RESPONSE; ARTICLE; AUTOIMMUNITY; BK VIRUS INFECTION; BLOOD SAMPLING; BODY MASS; CHRONIC GRAFT REJECTION; CYTOMEGALOVIRUS INFECTION; DISEASE DURATION; FEMALE; GLUCOSE BLOOD LEVEL; GRAFT FAILURE; GRAFT REJECTION; GRAFT SURVIVAL; HLA MATCHING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY DISEASE; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; KIDNEY PANCREAS TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PANCREAS BIOPSY; PANCREAS TRANSPLANTATION; PLASMAPHERESIS; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RECURRENT DISEASE; THROMBOSIS; BLOOD; CLINICAL TRIAL; DIABETES MELLITUS, TYPE 1; FOLLOW UP; IMMUNOLOGY; KAPLAN MEIER METHOD; KIDNEY TRANSPLANTATION; PANCREAS; PROSPECTIVE STUDY; RISK FACTOR; STATISTICAL MODEL; TREATMENT OUTCOME;

ADULT; AUTOANTIBODIES; AUTOANTIGENS; BIOLOGICAL MARKERS; DIABETES MELLITUS, TYPE 1; FEMALE; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY TRANSPLANTATION; LOGISTIC MODELS; MALE; PANCREAS; PANCREAS TRANSPLANTATION; PROSPECTIVE STUDIES; RECURRENCE; RISK FACTORS; TREATMENT OUTCOME;

EID: 84899084608     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/ctr.12337     Document Type: Article

References (21)

1. Eisenbarth GS. Type I diabetes mellitus: a chronic autoimmune disease. N Engl J Med 1986: 314: 1360.
2. Atkinson MA, MacLaren NK. The pathogenesis of insulin-dependent diabetes mellitus. N Engl J Med 1994: 331: 1428.
3. Sutherland DE, Goetz FC, Sibley RK. Recurrence of disease in pancreas transplants. Diabetes 1989: 38(Suppl 1): 85.
4. Tyden G, Reinholt FP, Sundkvist G, Bolinder J. Recurrence of autoimmune diabetes mellitus in recipients of cadaveric pancreatic grafts. N Engl J Med 1986: 335: 860.
5. Pugliese A, Reijonen H, Nepom J, Burke GW III. Recurrence of autoimmunity in pancreas transplant patients: research update. Diabetes Manag (Lond) 2011: 1: 229.
6. Laughlin E, Burke G, Pugliese A, Falk B, Nepom G. Recurrence of autoreactive antigen-specific CD4+ T-cells in autoimmune diabetes after pancreas transplantation. Clin Immunol 2008: 128: 23.
7. Vendrame F, Pileggi A, Laughlin E et al. Recurrence of type 1 diabetes after simultaneous pancreas-kidney transplantation, despite immunosuppression, is associated with autoantibodies and pathogenic autoreactive CD4 T-cells. Diabetes 2010: 59: 947.
8. Bosi E, Botazzo GF, Secchi A et al. Islet cell autoimmunity in type I diabetes patients after HLA-mismatched pancreas transplantation. Diabetes 1989: 38(Suppl 1): 82.
9. Braghi S, Bonifacio E, Secchi A, Di Carlo V, Pozza G, Bosi E. Modulation of humoral islet autoimmunity by pancreas allotransplantation influences allograft outcome in patients with type 1 diabetes. Diabetes 2000: 49: 218.
10. Thivolet C, Abou-Amara S, Martin X et al. Serological markers of recurrent beta cell destruction in diabetic patients undergoing pancreatic transplantation. Transplantation 2000: 69: 99.
11. Reijonen H, Mallone R, Heninger AK et al. GAD65-specific CD4+ T-cells with high antigen avidity are prevalent in peripheral blood of patients with type 1 diabetes. Diabetes 2004: 53: 1987.
12. Tisch R, McDevitt H. Insulin-dependent diabetes mellitus. Cell 1996: 85: 291.
13. Botazzo GF, Dean BM, McNally JM, Mackay EH, Swift PGF, Gamble DR. In situ characterization of autoimmune phenomenon: an expression of HLA molecules in pancreas in diabetic insulinitis. N Engl J Med 1985: 314: 353.
14. Sibley RK, Sutherland DE. Pancreas transplantation. An immunohistologic and histopathologic examination of 100 grafts. Am J Pathol 1987: 128: 151.
15. Eisenbarth GS, Stegall M. Islet and pancreatic transplantation - autoimmunity and alloimunity. N Engl J Med 1996: 335: 888.
16. Martins L, Malheiro J, Henriques AC et al. Pancreas-kidney transplantation and the evolution of pancreatic autoantibodies. Transplant Proc 2009: 41: 913.
17. Esmatjes E, Rodriguez-Villar C, Ricart MJ et al. Recurrence of immunological markers for type 1 (insulin-dependent) diabetes mellitus in immunosuppressed patients after pancreas transplantation. Transplantation 1998: 66: 128.
18. Jaeger C, Hering BJ, Dyrberg T, Federlin K, Bretzel RG. Islet cell autoantibodies and glutamic acid decarboxylase antibodies in patients with insulin-dependent diabetes mellitus undergoing kidney and islet-after kidney transplantation. Transplantation 1996: 62: 424.
19. Dieterle CD, Hierl FX, Gutt B et al. Insulin and islet autoantibodies after pancreas transplantation. Transpl Int 2005: 18: 1361.
20. Assalino M, Genevay M, Morel P, Demuylder-Mischler S, Tosco C, Berney T. Recurrence of type 1 diabetes after simultaneous pancreas-kidney transplantation in the absence of GAD and IA-2 autoantibodies. Am J Transplant 2012: 12: 492.
21. Gruessner AC. 2011 update on pancreas transplantation: comprehensive trend analysis of 25000 cases followed up over the course of twenty-four years at the International Pancreas Transplant Registry (IPTR). Rev Diabet Stud 2011: 8: 6.